SCHEMBL31735530

SCHEMBL31735530

N#CCc1ccc(-c2cc(F)cc(F)c2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 6/20 0.41
CYP11B2 P19099 4/20 0.41
KDM1A O60341 1/20 0.39
GRM5 P41594 5/20 0.38
LDHA P00338 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MET P08581 2/20 0.37
AURKA O14965 1/20 0.37
ABL1 P00519 1/20 0.37
NTRK1 P04629 1/20 0.37
LCK P06239 1/20 0.37
CSF1R P07333 1/20 0.37
RET P07949 1/20 0.37
PDGFRB P09619 1/20 0.37
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25297947 0.80 KMT2A (0.37) CYP11B1CYP11B2NPC1RAB9ASMN1; SMN2
SCHEMBL1289901 0.78 CYP11B1 (0.54) CYP11B1CYP11B2LDHANPC1RAB9A
SCHEMBL6260766 0.75 CYP11B1 (0.46) CYP11B1CYP11B2KDM1ANPC1RAB9A
SCHEMBL7452982 0.73 CYP11B2 (0.42) CYP11B1CYP11B2FLT3
SCHEMBL31716086 0.73 LDHA (0.51) CYP11B1CYP11B2LDHANPC1TP53
SCHEMBL19072737 0.73 GRM5 (0.47) KDM1AGRM5LDHANPC1MET
SCHEMBL1772141 0.72 KIF11 (0.41) CYP11B1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL7107602 0.71 CCR1 (0.57) CYP11B1CYP11B2GRM5NPC1TP53
SCHEMBL1019992 0.70 KDM4E (0.43) CYP11B1CYP11B2
SCHEMBL2322693 0.68 LDHA (0.55) KDM1ALDHANPC1TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245472-A1 COMPOUNDS AND RELATED METHODS USEFUL FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-11-27 WO disclosed